Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 3
1974 1
1976 1
1977 1
1979 1
1980 1
1981 1
1982 2
1984 1
1985 2
1986 1
1988 2
1990 1
1991 2
1993 1
1994 2
1996 1
1999 2
2000 1
2001 5
2003 3
2004 3
2005 3
2006 3
2007 4
2008 7
2009 4
2010 5
2011 12
2012 6
2013 16
2014 14
2015 20
2016 22
2017 15
2018 22
2019 31
2020 45
2021 44
2022 64
2023 71
2024 53
2025 45

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

499 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Noor NM, Lee JC, Bond S, Dowling F, Brezina B, Patel KV, Ahmad T, Banim PJ, Berrill JW, Cooney R, De La Revilla Negro J, de Silva S, Din S, Durai D, Gordon JN, Irving PM, Johnson M, Kent AJ, Kok KB, Moran GW, Mowat C, Patel P, Probert CS, Raine T, Saich R, Seward A, Sharpstone D, Smith MA, Subramanian S, Upponi SS, Wiles A, Williams HRT, van den Brink GR, Vermeire S, Jairath V, D'Haens GR, McKinney EF, Lyons PA, Lindsay JO, Kennedy NA, Smith KGC, Parkes M; PROFILE Study Group. Noor NM, et al. Among authors: din s. Lancet Gastroenterol Hepatol. 2024 May;9(5):415-427. doi: 10.1016/S2468-1253(24)00034-7. Epub 2024 Feb 22. Lancet Gastroenterol Hepatol. 2024. PMID: 38402895 Free PMC article. Clinical Trial.
Falls Risk in Relation to Activity Exposure in High-Risk Older Adults.
Del Din S, Galna B, Lord S, Nieuwboer A, Bekkers EMJ, Pelosin E, Avanzino L, Bloem BR, Olde Rikkert MGM, Nieuwhof F, Cereatti A, Della Croce U, Mirelman A, Hausdorff JM, Rochester L. Del Din S, et al. J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1198-1205. doi: 10.1093/gerona/glaa007. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31942969 Free PMC article. Clinical Trial.
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025.
Moran GW, Gordon M, Sinopolou V, Radford SJ, Darie AM, Vuyyuru SK, Alrubaiy L, Arebi N, Blackwell J, Butler TD, Chew T, Colwill M, Cooney R, De Marco G, Din S, Din S, Feakins R, Gasparetto M, Gordon H, Hansen R, Kok KB, Lamb CA, Limdi J, Liu E, Loughrey MB, McGonagle D, Patel K, Pavlidis P, Selinger C, Shale M, Smith PJ, Subramanian S, Taylor SA, Tun GSZ, Verma AM, Wong NACS; IBD guideline development group. Moran GW, et al. Among authors: din s. Gut. 2025 Jun 23;74(Suppl 2):s1-s101. doi: 10.1136/gutjnl-2024-334395. Gut. 2025. PMID: 40550582 Free article.
A Roadmap for the Human Gut Cell Atlas.
Zilbauer M, James KR, Kaur M, Pott S, Li Z, Burger A, Thiagarajah JR, Burclaff J, Jahnsen FL, Perrone F, Ross AD, Matteoli G, Stakenborg N, Sujino T, Moor A, Bartolome-Casado R, Bækkevold ES, Zhou R, Xie B, Lau KS, Din S, Magness ST, Yao Q, Beyaz S, Arends M, Denadai-Souza A, Coburn LA, Gaublomme JT, Baldock R, Papatheodorou I, Ordovas-Montanes J, Boeckxstaens G, Hupalowska A, Teichmann SA, Regev A, Xavier RJ, Simmons A, Snyder MP, Wilson KT; Gut Cell Atlas Consortium; Human Cell Atlas Gut Biological Network Consortium. Zilbauer M, et al. Among authors: din s. Nat Rev Gastroenterol Hepatol. 2023 Sep;20(9):597-614. doi: 10.1038/s41575-023-00784-1. Epub 2023 May 31. Nat Rev Gastroenterol Hepatol. 2023. PMID: 37258747 Free PMC article. Review.
Macrophages enhance sodium channel expression in cardiomyocytes.
Bogert NV, Therre M, Din S, Furkel J, Zhou X, El-Battrawy I, Heineke J, Schweizer PA, Akin I, Katus HA, Frey N, Leuschner F, Konstandin MH. Bogert NV, et al. Among authors: din s. Basic Res Cardiol. 2024 Dec;119(6):1063-1073. doi: 10.1007/s00395-024-01084-8. Epub 2024 Oct 9. Basic Res Cardiol. 2024. PMID: 39382673 Free PMC article.
British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease.
East JE, Gordon M, Nigam GB, Sinopoulou V, Bateman AC, Din S, Iacucci M, Kabir M, Lamb CA, Wilson A, Al Bakir I, Dhar A, Dolwani S, Faiz O, Hart A, Hayee B, Healey C, Leedham SJ, Novelli MR, Raine T, Rutter MD, Shepherd NA, Subramanian V, Vance M, Wakeman R, White L, Trudgill NJ, Morris AJ. East JE, et al. Among authors: din s. Gut. 2025 Apr 30:gutjnl-2025-335023. doi: 10.1136/gutjnl-2025-335023. Online ahead of print. Gut. 2025. PMID: 40306978 Free article.
Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's Disease.
Mirelman A, Volkov J, Salomon A, Gazit E, Nieuwboer A, Rochester L, Del Din S, Avanzino L, Pelosin E, Bloem BR, Della Croce U, Cereatti A, Thaler A, Roggen D, Mazza C, Shirvan J, Cedarbaum JM, Giladi N, Hausdorff JM. Mirelman A, et al. Among authors: del din s. Mov Disord. 2024 Feb;39(2):328-338. doi: 10.1002/mds.29689. Epub 2023 Dec 27. Mov Disord. 2024. PMID: 38151859
499 results